• RED RIBBON
• /
• s.65
• /
• pp.46-46
• /
• 2005

의료혜택을 받지 못하는 노숙자 및 국내거주 외국근로자를 대상으로 입원 및 수술비 등을 무료로 지원하는 사업을 실시하기로 발표하였다. 보건복지부의 무료진료사업 지침에 따르면 현재 입원 및 수술이 필요한 환자나 자원봉사단체 등은 적십자병원 또는 지방공사의료원을 방문하거나 입원 및 전원을 의뢰할 경우 우선적으로 진료를 받을 수 있다고 밝혔다.

• The Journal of Korean Medicine
• /
• v.40 no.3
• /
• pp.59-75
• /
• 2019

Objectives: The purpose of this study is to examine the current status of Korean medicine health technology assessment and explore realistic plans to activate it. Methods: We investigated all the applications for new health technology assessment related to Korean medicine from 2007 to 2016. The several expert meetings were held to draw out the barriers and improvement strategies of the new health technology assessment of Korean medicine field. Results: There were 31 cases in total except for duplications or reapplies falling into 3 main types. First, 19 of them were to try to enter a medical market and be covered by National Health Insurance. Eight cases were to apply western medicine technology as new health technology in Korean medicine area. The rest was 4 cases, which were totally not appropriate for the purpose of new health technology assessment system. According to the expert opinion, the obstacles of activation in new health technology assessment of Korean medicine were application of unstandardized technology, lack of understanding and experience, lack of clinical trial supporting system for Korean medicine, lack of committee members within the nHTA(new Health Technology Assessment) review board, ambiguous definition of medical practice and sharp conflict between western medicine and Korean medicine. Conclusions: Several suggestions were derived. First of all, to activate Korean medicine in the nHTA system, the existing system should be used sufficiently, and multifaceted efforts are needed to upgrade the system, if necessary. Also, self-help efforts, Korean medicine clinical trial supporting system and increasing R&D investment, establishing extra-committee for Korean medicine in nHTA could be needed. Finally, long-term strategy for improving collaboration between Korean medicine and western medicine should be considered.

• Quality Improvement in Health Care
• /
• v.4 no.1
• /
• pp.10-11
• /
• 1997

• Quality Improvement in Health Care
• /
• v.10 no.2
• /
• pp.266-277
• /
• 2003

• Quality Improvement in Health Care
• /
• v.10 no.2
• /
• pp.232-237
• /
• 2003

• The Korean Journal of Medicine
• /
• v.99 no.3
• /
• pp.134-139
• /
• 2024

Despite medical and invasive advancements, cardiovascular mortality attributable to ischemic heart disease, including acute coronary syndrome (ACS), persists at a substantial level. Clinical guidelines have been issued by the European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association to support clinicians in making appropriate decisions and improving the prognosis of ACS patients. ESC recently introduced a new ACS guideline in August 2023. This review discusses the recent modification in the diagnosis and management of early-phase ACS in the 2023 ESC guideline.

• Quality Improvement in Health Care
• /
• v.6 no.1_2
• /
• pp.18-31
• /
• 1999

• Quality Improvement in Health Care
• /
• v.6 no.1_2
• /
• pp.32-36
• /
• 1999

• Quality Improvement in Health Care
• /
• v.10 no.2
• /
• pp.238-253
• /
• 2003

• Proceedings of the Korean Society for Quality Management Conference
• /
• 2009.10a
• /
• pp.209-217
• /
• 2009